BMC Cancer

official impact factor 3.15

Open Access Highly Access Research article

miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments

Andreas Keller1*, Petra Leidinger2, Anne Borries1, Anke Wendschlag1, Frank Wucherpfennig1, Matthias Scheffler1, Hanno Huwer3, Hans-Peter Lenhof4 and Eckart Meese2

Author Affiliations

1 febit biomed gmbh, Im Neuenheimer Feld 519, 69120 Heidelberg, Germany

2 Department of Human Genetics, Medical School, Saarland University, Building 60, 66421 Homburg, Germany

3 Department of Cardiothoracic Surgery, Voelklingen Heart Center, 66333 Voelklingen, Germany

4 Center for Bioinformatics, Saarland University, Building E 1 1, 66041Saarbruecken, Germany

For all author emails, please log on.

BMC Cancer 2009, 9:353 doi:10.1186/1471-2407-9-353

Published: 6 October 2009

Additional files

Additional file 1:

Table S1. Details of all miRNAs for the miRVANA screening (columns A-I), MPEA Assay (columns K-S) and the MI (columns U-V). Significant miRNAs are colored.

Format: XLS Size: 352KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data

Additional file 2:

Table S2. Mutual Information of biomarkers. This table contains for each miRNA biomarker the Mutual Information (MI) together with the enrichment as compared to the background MI. The miRNAs with MI higher than the highest background MI are colored red, the miRNAs with MI values higher than highest 5% background MI's in blue.

Format: XLS Size: 141KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data